Sisram Medical (1696) Stock Overview
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
1696 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sisram Medical Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.20 |
| 52 Week High | HK$8.07 |
| 52 Week Low | HK$3.16 |
| Beta | 1.09 |
| 1 Month Change | -9.48% |
| 3 Month Change | -28.57% |
| 1 Year Change | 32.49% |
| 3 Year Change | -38.86% |
| 5 Year Change | 59.70% |
| Change since IPO | -48.28% |
Recent News & Updates
Sisram Medical's (HKG:1696) Problems Go Beyond Weak Profit
Sep 26
Sisram Medical Ltd (HKG:1696) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Sep 17Why Sisram Medical Ltd (HKG:1696) Could Be Worth Watching
Sep 05Recent updates
Sisram Medical's (HKG:1696) Problems Go Beyond Weak Profit
Sep 26Sisram Medical Ltd (HKG:1696) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Sep 17Why Sisram Medical Ltd (HKG:1696) Could Be Worth Watching
Sep 05Sisram Medical (HKG:1696) Is Paying Out Less In Dividends Than Last Year
Aug 14Investors Holding Back On Sisram Medical Ltd (HKG:1696)
Jul 21We Think Shareholders May Want To Consider A Review Of Sisram Medical Ltd's (HKG:1696) CEO Compensation Package
Jun 17Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
May 29Is Sisram Medical (HKG:1696) A Risky Investment?
Apr 14Sisram Medical's (HKG:1696) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 26Market Cool On Sisram Medical Ltd's (HKG:1696) Earnings
Feb 19Investors Could Be Concerned With Sisram Medical's (HKG:1696) Returns On Capital
Dec 11What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Shareholder Returns
| 1696 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -9.5% | -7.6% | -4.6% |
| 1Y | 32.5% | 57.6% | 34.0% |
Return vs Industry: 1696 underperformed the Hong Kong Medical Equipment industry which returned 57.2% over the past year.
Return vs Market: 1696 underperformed the Hong Kong Market which returned 34.5% over the past year.
Price Volatility
| 1696 volatility | |
|---|---|
| 1696 Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 1696 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1696's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 1,040 | Lior Dayan | www.sisram-medical.com |
Sisram Medical Ltd engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio for various wellness businesses, including hair growth and removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue re-modelling injectables, personal care, and aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company also manufactures, distributes, and sells medical equipment.
Sisram Medical Ltd Fundamentals Summary
| 1696 fundamental statistics | |
|---|---|
| Market cap | HK$1.97b |
| Earnings (TTM) | HK$160.39m |
| Revenue (TTM) | HK$2.69b |
Is 1696 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1696 income statement (TTM) | |
|---|---|
| Revenue | US$345.86m |
| Cost of Revenue | US$135.14m |
| Gross Profit | US$210.72m |
| Other Expenses | US$190.12m |
| Earnings | US$20.60m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.044 |
| Gross Margin | 60.93% |
| Net Profit Margin | 5.96% |
| Debt/Equity Ratio | 1.0% |
How did 1696 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/21 05:34 |
| End of Day Share Price | 2025/11/21 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sisram Medical Ltd is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |
| Shiyu Chen | China International Capital Corporation Limited |